Combining 3D cell culture & AI to translate drugs to clinical success
Company was acquired
Event Year: 2020
Company was acquired
Event Year: 2020
Known Medicine leveraged a unique approach by integrating patient-specific 3D cell culture techniques with artificial intelligence to enhance drug translation and improve clinical success rates. The process involved receiving patient tumor samples, disaggregating them, and creating thousands of micro-tumors. Each of these micro-tumors was then treated with a variety of drugs to identify the most effective treatment options for individual patients. This innovative method aimed to personalize cancer treatment and increase the likelihood of positive patient outcomes.
Known Medicine leveraged a unique approach by integrating patient-specific 3D cell culture techniques with artificial intelligence to enhance drug translation and improve clinical success rates. The process involved receiving patient tumor samples, disaggregating them, and creating thousands of micro-tumors. Each of these micro-tumors was then treated with a variety of drugs to identify the most effective treatment options for individual patients. This innovative method aimed to personalize cancer treatment and increase the likelihood of positive patient outcomes.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Healthcare
Healthcare
Healthcare
Healthcare
Team size: 17
Hiring: No
Team size: 17
Hiring: No